Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 48INDUSTRY 5OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 133Stomach Neoplasms 107Carcinoma, Hepatocellular 73Rectal Neoplasms 64Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Neoplasms 28Neoplasm Metastasis 20Esophageal Squamous Cell Carcinoma 20Gastrointestinal Neoplasms 19Cholangiocarcinoma 14Liver Neoplasms 13Breast Neoplasms 13Barrett Esophagus 9Lung Neoplasms 8Adenoma 8Motor Activity 7Liver Cirrhosis 7Digestive System Neoplasms 7Colonic Polyps 7Adenomatous Polyposis Coli 7Biliary Tract Neoplasms 6Anastomotic Leak 6Sarcopenia 5Inflammatory Bowel Diseases 5Hypertension, Portal 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4

Interventions

titanium silicide 1apatinib 1S 1 (combination) 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced Gastric Cancer × Gastrointestinal × Clear all
NCT03954756 2019-05-17

Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

Henan Cancer Hospital

Phase 2 Unknown
35 enrolled
Gastrointestinal

Advanced Gastric Cancer

NCT03137004 2017-05-08

Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
47 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡